At Overlake, we partner with our cancer patients to develop cancer treatment plans based on each individual’s needs and goals. Overlake participates in several national accreditation programs related to our cancer services. One of these is the Commission on Cancer (CoC). The CoC comprises a group of professional organizations dedicated to improving survival and quality of life for cancer patients through:
- Standard-setting (practicing the best standards of care)
- Promoting cancer prevention and cancer screening
- Conducting and supporting research, and
- Monitoring of comprehensive quality cancer care
Overlake is one of 42 CoC-accredited Cancer Programs in Washington
Overlake continuously monitors our adherence to national standards of care, providing our patients the best chance to overcome their cancer. The CoC has established five accountability measures representing the standard of care based on clinical trial evidence. Four pertain to breast cancer treatment and one pertains to colon cancer treatment:
#1 Radiation is given within one year of diagnosis for women younger than 70 whose breast cancer surgery was a lumpectomy.
#2 A combination of chemotherapy drugs is given or considered within four months of diagnosis for women younger than 70 with hormone-receptor negative breast cancer which has not spread to distant sites.
#3 Hormone therapy is given or considered within one year of diagnosis for women with hormone-receptor positive breast cancer which has not spread to distant sites.
#4 Radiation is given or considered within one year of diagnosis for breast cancer in patients who had a mastectomy and had four or more lymph nodes removed.
#5 Adjuvant chemo (Chemotherapy after surgery) is considered or administered within four months of diagnosis for patients younger than 80 with Stage III colon cancer.
The CoC provides each accredited program with a quality improvement report each year. Overlake’s most recent report compared our performance with national performance rates for 2014. We outperformed the national performance rates for four out of the five measures and were within 1/10th of a percentage point for the fifth measure.
Learn more about how the Overlake cancer team tailors breast cancer treatment to older patients.